Morgan Mace

516 total citations
8 papers, 351 citations indexed

About

Morgan Mace is a scholar working on Genetics, Hematology and Oncology. According to data from OpenAlex, Morgan Mace has authored 8 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Hematology and 2 papers in Oncology. Recurrent topics in Morgan Mace's work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Morgan Mace is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Acute Myeloid Leukemia Research (2 papers). Morgan Mace collaborates with scholars based in United States and France. Morgan Mace's co-authors include Elias Jabbour, Hagop M. Kantarjian, Naval Daver, Caitlin R. Rausch, Christopher B. Benton, Guillermo Garcia‐Manero, Nitin Jain, Courtney D. DiNardo, Kapil N. Bhalla and Naveen Pemmaraju and has published in prestigious journals such as Blood, American Journal of Hematology and American Journal of Health-System Pharmacy.

In The Last Decade

Morgan Mace

8 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Morgan Mace United States	4	244	158	84	76	58	8	351
Raimundo García Spain	7	163 0.7×	53 0.3×	93 1.1×	40 0.5×	38 0.7×	8	279
Yoo Jin Lee South Korea	10	185 0.8×	83 0.5×	77 0.9×	59 0.8×	69 1.2×	50	334
Fabio Guolo Italy	10	112 0.5×	78 0.5×	127 1.5×	36 0.5×	42 0.7×	46	306
Jan Davisson United States	6	333 1.4×	228 1.4×	52 0.6×	120 1.6×	93 1.6×	8	451
Evelyne D’Incan France	10	311 1.3×	119 0.8×	98 1.2×	88 1.2×	77 1.3×	23	410
Joanna Van Elk United States	6	194 0.8×	120 0.8×	70 0.8×	27 0.4×	37 0.6×	7	341
Mohit Narang United States	12	435 1.8×	298 1.9×	272 3.2×	74 1.0×	64 1.1×	64	526
Joaquín Sánchez‐García Spain	10	169 0.7×	48 0.3×	77 0.9×	65 0.9×	46 0.8×	26	306
Kiyomi Morita United States	10	140 0.6×	54 0.3×	76 0.9×	55 0.7×	90 1.6×	31	254
Kazuhiro Yago Japan	9	72 0.3×	136 0.9×	60 0.7×	29 0.4×	25 0.4×	27	289

Countries citing papers authored by Morgan Mace

Since Specialization

Citations

This map shows the geographic impact of Morgan Mace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan Mace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan Mace more than expected).

Fields of papers citing papers by Morgan Mace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morgan Mace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan Mace. The network helps show where Morgan Mace may publish in the future.

Co-authorship network of co-authors of Morgan Mace

This figure shows the co-authorship network connecting the top 25 collaborators of Morgan Mace. A scholar is included among the top collaborators of Morgan Mace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morgan Mace. Morgan Mace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Rogers, Jane E., Cheuk Hong Leung, Van Du Nguyen, et al.. (2024). Direct Clinical Pharmacist-Patient Telephone Follow-Up: A Focus on GI Medical Oncology Symptom Management. JCO Oncology Practice. 20(6). 808–815. 1 indexed citations

2.

DiNardo, Courtney D., Caitlin R. Rausch, Christopher B. Benton, et al.. (2017). Clinical experience with the BCL2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies. American Journal of Hematology. 93(3). 401–407. 293 indexed citations

3.

Rausch, Caitlin R., Courtney D. DiNardo, Tapan M. Kadia, et al.. (2017). Results of Off-Label Venetoclax Use in Combination with Low-Intensity Chemotherapy in Patients with Relapsed and Refractory Myeloid Malignancies. Blood. 130. 1356–1356. 3 indexed citations

4.

Do, Bryan, et al.. (2016). Idelalisib for treatment of B-cell malignancies. American Journal of Health-System Pharmacy. 73(8). 547–555. 17 indexed citations

5.

Mace, Morgan, et al.. (2015). Which tyrosine-kinase inhibitor to use first in chronic phase chronic myelogenous leukemia?. Expert Opinion on Pharmacotherapy. 16(7). 999–1007. 12 indexed citations

6.

Mace, Morgan, et al.. (2015). Blinatumomab for the treatment of adult acute lymphoblasticleukemia. Drugs of today. 51(4). 231–231. 3 indexed citations

7.

Mace, Morgan, et al.. (2011). Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital.. PubMed. 36(1). 33–6. 3 indexed citations

8.

Guellec, Chantal Le, Jean‐Marc Besnier, Frédéric Bastides, et al.. (2001). Therapeutic Drug Monitoring of HIV Protease Inhibitors Using High-Performance Liquid Chromatography With Ultraviolet or Photodiode Array Detection. Therapeutic Drug Monitoring. 23(6). 679–688. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact